MedWatch

Company behind satiety pill is looking for partners

A Danish CRO company, which has already received millions from The Danish National Advanced Technology Foundation for the development of a so-called satiety pill, is expected to form a Big Pharma-partnership in the near future.

Foto: Colourbox

“We began the project initially, we are running the project, and then we have teamed up with skilled researchers from the University of Copenhagen and Gentofte Hospital,” says co-founder and CEO in the CRO company Gubra, Niels Vrang, about the project described here on Medwatch last week.

Allerede abonnent? Log ind.

Læs hele artiklen

Få adgang i 14 dage for 0 kr.
Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

FDA godkender mikrobiommiddel fra Ferring

Medicinalselskabet Ferring Pharmaceuticals har fået amerikansk godkendelse af sin biologiske kandidat mod tarminfektioner med den ondartede bakterie clostridium difficile.

Relaterede

Seneste nyt

MedWatch job

Se flere jobs

Se flere jobs

Watch job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier